Other languages Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.1373 ^USD	+3.47%		+32.27%	-19.04%

Apr. 03	Sector Update: Health Care Stocks Softer Late Afternoon	MT
Apr. 03	Sector Update: Health Care	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 03
Sector Update: Health Care	Apr. 03
Top Midday Gainers	Apr. 03
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	Mar. 27
Kintara Therapeutics Continues to Evaluate Strategic Options	Feb. 15
Kintara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14
Kintara Therapeutics, Inc. Announces Initiation of Rem-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	Feb. 12
Wall Street Set for Cautious Opening in Final Trading Day of a Bullish 2023	Dec. 29
Index Futures Edge Higher to End Mostly Positive Year on High Note	Dec. 29
Top Premarket Gainers	Dec. 29
Kintara Therapeutics Initiates Strategic Review to Optimize Shareholder Value	Dec. 07
Kintara Therapeutics Initiates Review of Strategic Alternatives	Dec. 06
Kintara Therapeutics, Inc. Announces Executive Changes	Nov. 21
Kintara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 13
Sector Update: Health Care Stocks Rise Late Afternoon	23-10-31
Sector Update: Health Care	23-10-31
Top MIdday Decliners	23-10-31
Kintara Therapeutics Announces Preliminary Topline Results from GBM AGile Study	23-10-31
Kintara Therapeutics, Inc. Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting	23-09-25
Kintara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Other languages

Filters